NIH chief: 'Wacky' science needs our support

In a recent speech in Chicago NIH chief Francis Collins talked about the need to support "wacky" research projects, the lack of scientists from disadvantaged groups and how obesity could make this the first generation that doesn't live longer than its parents' generation. "Not being able to understand a Bayesian analysis will no longer be tolerated," he added. Story

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.